טוען...
p53 overexpression increases chemosensitivity in multidrug resistant osteosarcoma cell lines
PURPOSE: Multidrug resistance (MDR) is a major obstacle to the successful treatment of osteosarcoma with chemotherapy. Effectiveness of cancer therapy correlates with the ability to induce a p53-dependent apoptotic response. p53 is a tumor suppressor gene that is mutated in 22% of osteosarcomas. Whi...
שמור ב:
| הוצא לאור ב: | Cancer Chemother Pharmacol |
|---|---|
| Main Authors: | , , , , , , |
| פורמט: | Artigo |
| שפה: | Inglês |
| יצא לאור: |
2015
|
| נושאים: | |
| גישה מקוונת: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4749432/ https://ncbi.nlm.nih.gov/pubmed/26698867 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s00280-015-2944-z |
| תגים: |
הוספת תג
אין תגיות, היה/י הראשונ/ה לתייג את הרשומה!
|